These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 27157288)
1. Glioblastoma Invoking "Killer" Rabbits of the Middle Ages. Massoud TF; Kalnins A World Neurosurg; 2016 Aug; 92():140-141. PubMed ID: 27157288 [TBL] [Abstract][Full Text] [Related]
2. State of the Art Treatment and Surveillance Imaging of Glioblastomas. Margiewicz S; Cordova C; Chi AS; Jain R Semin Roentgenol; 2018 Jan; 53(1):23-36. PubMed ID: 29405952 [No Abstract] [Full Text] [Related]
3. [Unusual course of glioblastoma multiforme as calcinosis in CCT]. Victor S; Altay Y; Schneider T Neurochirurgia (Stuttg); 1993 Sep; 36(5):167-71. PubMed ID: 8272170 [TBL] [Abstract][Full Text] [Related]
4. Imaging Genetic Heterogeneity in Glioblastoma and Other Glial Tumors: Review of Current Methods and Future Directions. Chow D; Chang P; Weinberg BD; Bota DA; Grinband J; Filippi CG AJR Am J Roentgenol; 2018 Jan; 210(1):30-38. PubMed ID: 28981352 [TBL] [Abstract][Full Text] [Related]
7. Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma. Shiroishi MS; Boxerman JL; Pope WB Neuro Oncol; 2016 Apr; 18(4):467-78. PubMed ID: 26364321 [TBL] [Abstract][Full Text] [Related]
8. Benefit of dual-energy CT iodine overlay technique for T1-hyperintense brain lesion. Lee Y; Seo HS; Je BK; Kim SD; Oh HE Neurology; 2017 Sep; 89(13):1426-1427. PubMed ID: 28947579 [No Abstract] [Full Text] [Related]
9. [Secondary intraspinal localizations of glioblastoma. Apropos of a case]. Aghakhani N; Roux FX; Fallet-Bianco C; Devaux B Neurochirurgie; 1995; 41(5):363-6. PubMed ID: 8577358 [TBL] [Abstract][Full Text] [Related]
10. MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction. Kim BR; Choi SH; Yun TJ; Lee ST; Park CK; Kim TM; Kim JH; Park SW; Sohn CH; Park SH; Kim IH PLoS One; 2016; 11(11):e0166096. PubMed ID: 27835666 [TBL] [Abstract][Full Text] [Related]
11. Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma. Gzell CE; Wheeler HR; McCloud P; Kastelan M; Back M J Neurooncol; 2016 May; 128(1):67-74. PubMed ID: 26879084 [TBL] [Abstract][Full Text] [Related]
12. Delayed Diagnosis of Glioblastoma Multiforme Presenting With Atypical Psychiatric Symptoms. Munjal S; Pahlajani S; Baxi A; Ferrando S Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 28033459 [No Abstract] [Full Text] [Related]
13. Cystic supratentorial mass in a middle-aged patient: MR imaging findings with histopathologic correlation. De Wilde C; Dekeyzer S; Van den Broecke C; Acou M; Bauters W; Achten E Acta Neurol Belg; 2017 Dec; 117(4):909-913. PubMed ID: 28948537 [No Abstract] [Full Text] [Related]
14. 18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria. Bolcaen J; Acou M; Boterberg T; Vanhove C; De Vos F; Van den Broecke C; Van Holen R; Deblaere K; Goethals I Nucl Med Commun; 2017 Mar; 38(3):242-249. PubMed ID: 27984537 [TBL] [Abstract][Full Text] [Related]
15. Predictive value of MRI features on glioblastoma. Ma X; Liu J Eur Radiol; 2023 Jun; 33(6):4472-4474. PubMed ID: 37020071 [No Abstract] [Full Text] [Related]
16. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-1971. N Engl J Med; 1971 Aug; 285(7):394-401. PubMed ID: 4326624 [No Abstract] [Full Text] [Related]
17. Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma. Tensaouti F; Khalifa J; Lusque A; Plas B; Lotterie JA; Berry I; Laprie A; Cohen-Jonathan Moyal E; Lubrano V Neuroradiology; 2017 Oct; 59(10):1013-1020. PubMed ID: 28842741 [TBL] [Abstract][Full Text] [Related]
18. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study. Czarnek N; Clark K; Peters KB; Mazurowski MA J Neurooncol; 2017 Mar; 132(1):55-62. PubMed ID: 28074320 [TBL] [Abstract][Full Text] [Related]